Bromodomain and extra-terminal (BET) proteins target Moloney murine leukemia virus integration to transcription start sites

被引：0
|
作者：
Jan De Riick
Christine de Kogel
Jonas Demeulemeester
Sofie Vets
Nirav Malani
Frederic D Bushman
Katrien Busschots
Steven Husson
Rik Gijsbers
Zeger Debyser
机构：
[1] KU Leuven,Laboratory for Molecular Virology and Gene Therapy
[2] University of Pennsylvania School of Medicine,Department of Microbiology
[3] University Hasselt,Biomedical Research Institute
[4] University of Antwerp,Systemic Physiological & Ecotoxicological Research
来源：
Retrovirology | / 10卷
关键词：
Transcription Start Site; Murine Leukemia Virus; Chromatin Interaction; Vector Transduction; Murine Leukemia Virus Vector;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Bromodomain and extra-terminal motif proteins regulate linear and circular PVT1 in acute myeloid leukemia cells under normoxia and hypoxia
    Ghetti, Martina
    Vannini, Ivan
    Bruno, Samantha
    Liverani, Chiara
    Traversa, Debora
    Montanaro, Lorenzo
    Napolitano, Roberta
    di Rora, Andrea Ghelli Luserna
    Ibrahim, Toni
    Storlazzi, Clelia Tiziana
    Martinelli, Giovanni
    Simonetti, Giorgia
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Inhibition of Moloney murine leukemia virus integration using polyamides targeting the long-terminal repeat sequences
    Yang, F
    Belitsky, JM
    Villanueva, RA
    Dervan, PB
    Roth, MJ
    BIOCHEMISTRY, 2003, 42 (20) : 6249 - 6258
  • [43] The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors
    Abruzzese, Maria Pia
    Bilotta, Maria Teresa
    Fionda, Cinzia
    Zingoni, Alessandra
    Soriani, Alessandra
    Petrucci, Maria Teresa
    Ricciardi, Maria Rosaria
    Molfetta, Rosa
    Paolini, Rossella
    Santoni, Angela
    Cippitelll, Marco
    CELL DEATH & DISEASE, 2019, 10 (4)
  • [44] Bromodomain and extra-terminal BET inhibitors induce TP53 independent apoptosis, maturation and oncoprotein degradation in NPM1 mutated acute myeloid leukemia
    Braun, Thorsten
    Coude, Marie-Magdelaine
    Berrou, Jeannig
    Djamai, Hanene
    Dupont, Melanie
    Kaci, Anna
    Delord, Marc
    Itzykson, Raphael
    Raffoux, Emmanuel
    Berthier, Caroline
    de The, Hugues
    Baruchel, Andre
    Gardin, Claude
    Dombret, Herve
    CANCER RESEARCH, 2018, 78 (13)
  • [45] MOLONEY MURINE LEUKEMIA-VIRUS INTEGRATION PROTEIN PRODUCED IN YEAST BINDS SPECIFICALLY TO VIRAL ATT SITES
    BASU, S
    VARMUS, HE
    JOURNAL OF VIROLOGY, 1990, 64 (11) : 5617 - 5625
  • [46] Initial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer
    Hilton, J.
    Cristea, M. C.
    Voskoboynik, M.
    Postel-Vinay, S.
    Edenfield, W.
    Gavai, A.
    Wee, S.
    Srivastava, N.
    Klippel, A.
    Jackson, D.
    Apfel, A.
    Chasalow, S. D.
    Williams, D.
    Donovan, M.
    Fischer, B.
    Khaldoyanidi, S.
    Diamond, J. R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
    Chan, Kwok-Ho
    Zengerle, Michael
    Testa, Andrea
    Ciulli, Alessio
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 504 - 513
  • [48] Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB)
    Hottinger, Andreas Felix
    Sanson, Marc
    Moyal, Elizabeth
    Delord, Jean-Pierre
    De Micheli, Rita
    Rezai, Keyvan
    Leung, Abraham C. F.
    Perez, Susan
    Bekradda, Mohamed
    Lachaux, Nicolas
    Lokiec, Francois Marc
    Chinot, Olivier L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines
    Andrielle Castilho-Fernandes
    Aparecida Maria Fontes
    Kuruvilla Joseph Abraham
    Marcela Cristina Corrêa de Freitas
    Nathalia Gonsales da Rosa
    Virginia Picanço-Castro
    Elisa Maria de Sousa Russo-Carbolante
    Dimas Tadeu Covas
    Biotechnology Letters, 2015, 37 : 991 - 1001
  • [50] Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines
    Castilho-Fernandes, Andrielle
    Fontes, Aparecida Maria
    Abraham, Kuruvilla Joseph
    Correa de Freitas, Marcela Cristina
    da Rosa, Nathalia Gonsales
    Picanco-Castro, Virginia
    de Sousa Russo-Carbolante, Elisa Maria
    Covas, Dimas Tadeu
    BIOTECHNOLOGY LETTERS, 2015, 37 (05) : 991 - 1001
12345